Table 4.
Subgroups | No. of events/studies | Prevalence of resistant gene % (CI) |
n/N | Heterogeneity Test | |
---|---|---|---|---|---|
I2 (%) | P-value | ||||
Overall prevalence of TEM genes | 5 | 39.5 (15.4–70.1) | 241/484 | 96.6 | < 0.001 |
Overall prevalence of SHV-11 genes | 7 | 41.8 (16.2–72.6) | 350/1117 | 98.1 | < 0.001 |
Overall prevalence of CTX-M-1 Genes |
5 | 41.9 (21.6–65.4) | 229/826 | 95.7 | < 0.001 |
Overall prevalence of CTX-M-15 genes | 5 | 35.3 (17.1–58.9) | 153/548 | 95.0 | < 0.001 |
Overall prevalence of KPC-2 genes | 6 | 14.6 (6.0–31.4) | 301/2031 | 97.1 | < 0.001 |
Overall prevalence of NDM-1 genes | 5 | 6.7 (1.7–23.4) | 108/1452 | 95.6 | < 0.001 |
CI, confidence interval; n, number of events (resistance-mediated genes); N, total number of Klebsiella pneumoniae from the included studies